Pharmarise Holdings (TSE:2796) Debt-to-Revenue : N/A (As of Nov. 2024)

Pharmarise Holdings Debt-to-Revenue Chart

Pharmarise Holdings Annual Data
	Trend	May15	May16	May17	May18	May19	May20	May21	May22	May23	May24
Debt-to-Revenue		Get a 7-Day Free Trial					0.22	0.20	0.19	0.18	0.23

Pharmarise Holdings Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Nov24
Debt-to-Revenue	Get a 7-Day Free Trial															0.16	0.12	0.19	0.23	N/A

Competitive Comparison of Pharmarise Holdings's Debt-to-Revenue

For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmarise Holdings's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pharmarise Holdings's Debt-to-Revenue falls into.

Pharmarise Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Pharmarise Holdings's Debt-to-Revenue for the fiscal year that ended in May. 2024 is calculated as

Pharmarise Holdings's annualized Debt-to-Revenue for the quarter that ended in Nov. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Nov. 2024) Revenue data.

Pharmarise Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmarise Holdings Business Description